Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Parkinson's Disease Treatment is the First and Only Carbidopa/Levodopa (CD/LD) TabletDesigned to be Divided for Precise Dosing
ALPHARETTA, Ga., Feb. 14, 2022 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, an Alora Pharmaceutic... Biopharmaceuticals, Neurology, FDA Avion Pharmaceuticals, Alora Pharmaceuticals, Parkinson's Disease, DHIVY
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Carbidopa/Levodopa | Marketing | Neurology | Parkinson's Disease | Pharmaceuticals